Foamix Pharmaceuticals Ltd. Proceeds from Warrant Exercises
Foamix Pharmaceuticals Ltd. reported Proceeds from Warrant Exercises of $840.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. proceeds from warrant exercises for the quarter ending 2018-12-31 was $0.00.
- Foamix Pharmaceuticals Ltd. proceeds from warrant exercises for the quarter ending 2018-09-30 was $0.00.
- Foamix Pharmaceuticals Ltd. proceeds from warrant exercises for fiscal 2018 was $840.00K.
- Foamix Pharmaceuticals Ltd. proceeds from warrant exercises for fiscal 2016 was $1.29M, a 43.33% decline from fiscal 2015.
- Foamix Pharmaceuticals Ltd. proceeds from warrant exercises for fiscal 2015 was $2.29M.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $840.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $840.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $840.00K 10-Q · filed 2019-08-07 | |||
| 2016-12-31 | $1.29M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $2.29M 10-K · filed 2018-03-01 | |||
| 2015-06-30 | $2.13M 6-K · filed 2016-08-10 |